Nukkleus Statistics
Total Valuation
Nukkleus has a market cap or net worth of $46.34 million. The enterprise value is $47.02 million.
Important Dates
The next estimated earnings date is Monday, February 24, 2025, after market close.
| Earnings Date | Feb 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nukkleus has 2.11 million shares outstanding. The number of shares has decreased by -96.66% in one year.
| Current Share Class | 2.11M |
| Shares Outstanding | 2.11M |
| Shares Change (YoY) | -96.66% |
| Shares Change (QoQ) | +2.18% |
| Owned by Insiders (%) | 102.16% |
| Owned by Institutions (%) | 7.00% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.04 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06
| Current Ratio | 0.06 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -182.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -115.02% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 137.66% |
| Revenue Per Employee | $896,051 |
| Profits Per Employee | -$2.27M |
| Employee Count | 12 |
| Asset Turnover | 1.31 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +232.55% in the last 52 weeks. The beta is -6.59, so Nukkleus's price volatility has been lower than the market average.
| Beta (5Y) | -6.59 |
| 52-Week Price Change | +232.55% |
| 50-Day Moving Average | 19.92 |
| 200-Day Moving Average | 7.76 |
| Relative Strength Index (RSI) | 45.87 |
| Average Volume (20 Days) | 1,493,670 |
Short Selling Information
The latest short interest is 118,373, so 5.60% of the outstanding shares have been sold short.
| Short Interest | 118,373 |
| Short Previous Month | 189,980 |
| Short % of Shares Out | 5.60% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, Nukkleus had revenue of $10.75 million and -$27.25 million in losses. Loss per share was -$17.80.
| Revenue | 10.75M |
| Gross Profit | 502,525 |
| Operating Income | -15.15M |
| Pretax Income | -24.50M |
| Net Income | -27.25M |
| EBITDA | -14.54M |
| EBIT | -15.15M |
| Loss Per Share | -$17.80 |
Full Income StatementBalance Sheet
The company has $6,138 in cash and $1.95 million in debt, giving a net cash position of -$1.94 million or -$0.92 per share.
| Cash & Cash Equivalents | 6,138 |
| Total Debt | 1.95M |
| Net Cash | -1.94M |
| Net Cash Per Share | -$0.92 |
| Equity (Book Value) | -12.23M |
| Book Value Per Share | -6.61 |
| Working Capital | -11.42M |
Full Balance SheetCash Flow
| Operating Cash Flow | -3.22M |
| Capital Expenditures | n/a |
| Free Cash Flow | -3.22M |
| FCF Per Share | -$1.53 |
Full Cash Flow StatementMargins
Gross margin is 4.67%, with operating and profit margins of -140.91% and -253.45%.
| Gross Margin | 4.67% |
| Operating Margin | -140.91% |
| Pretax Margin | -253.45% |
| Profit Margin | -253.45% |
| EBITDA Margin | -135.22% |
| EBIT Margin | -140.91% |
| FCF Margin | n/a |